Correction: Real‑World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis

Peter Youssef^{1

2

3}, Sabina Ciciriello^{3

4}, Talib Tahir⁵, Joanna Leadbetter⁶, Belinda Butcher^{6

7}, Miriam Calao⁸, Nicole Walsh⁸, Catherine O'Sullivan³, Tegan Smith³, Geoffrey Littlejohn^{9

10

11}

Affiliations

¹ Institute for Musculoskeletal Health at University of Sydney, Sydney, NSW, Australia.
² Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
³ OPAL Rheumatology Ltd, Sydney, NSW, Australia.
⁴ The Royal Melbourne Hospital, Melbourne, VIC, Australia.
⁵ Coburg Rheumatology Service, Coburg, VIC, Australia.
⁶ WriteSource Medical Pty Ltd, Lane Cove, NSW, Australia.
⁷ School of Biomedical Sciences, University of New South Wales, Kensington, NSW, Australia.
⁸ AbbVie Pty Ltd., Mascot, NSW, Australia.
⁹ OPAL Rheumatology Ltd, Sydney, NSW, Australia. geoff.littlejohn@monash.edu.
¹⁰ Monash University, Clayton, VIC, Australia. geoff.littlejohn@monash.edu.
¹¹ OPAL Rheumatology Ltd, 156-158 Bellerine Street, Geelong, VIC, 3220, Australia. geoff.littlejohn@monash.edu.

Published Erratum

Peter Youssef et al. Rheumatol Ther. 2025 Dec.

. 2025 Dec;12(6):1193-1196.

doi: 10.1007/s40744-025-00782-6.

¹ Institute for Musculoskeletal Health at University of Sydney, Sydney, NSW, Australia.
² Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
³ OPAL Rheumatology Ltd, Sydney, NSW, Australia.
⁴ The Royal Melbourne Hospital, Melbourne, VIC, Australia.
⁵ Coburg Rheumatology Service, Coburg, VIC, Australia.
⁶ WriteSource Medical Pty Ltd, Lane Cove, NSW, Australia.
⁷ School of Biomedical Sciences, University of New South Wales, Kensington, NSW, Australia.
⁸ AbbVie Pty Ltd., Mascot, NSW, Australia.
⁹ OPAL Rheumatology Ltd, Sydney, NSW, Australia. geoff.littlejohn@monash.edu.
¹⁰ Monash University, Clayton, VIC, Australia. geoff.littlejohn@monash.edu.
¹¹ OPAL Rheumatology Ltd, 156-158 Bellerine Street, Geelong, VIC, 3220, Australia. geoff.littlejohn@monash.edu.

No abstract available

Figures

Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.
Youssef P, Ciciriello S, Tahir T, Leadbetter J, Butcher B, Calao M, Walsh N, O'Sullivan C, Smith T, Littlejohn G. Youssef P, et al. Rheumatol Ther. 2025 Feb;12(1):173-202. doi: 10.1007/s40744-024-00736-4. Epub 2025 Jan 6. Rheumatol Ther. 2025. PMID: 39757285 Free PMC article.